Urinary Tract Infection Research Today is a free monthly online journal that collates and summarizes the latest research about Urinary Tract Infection, including details on uti, causes, prevention, diet, treatment.

Volume 2 (2005), Issue 6 (June)

1. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model.
   Antonie Van Leeuwenhoek, 88(1): 25-34. [Abstract] [Full-text]
2. Compliance with guidelines for the medical care of first urinary tract infections in infants: a population-based study.
   Pediatrics, 115(6): 1474-8. [Abstract] [Full-text]
3. Effect of L-methionine supplementation on plasma homocysteine and other free amino acids: a placebo-controlled double-blind cross-over study.
   Eur J Clin Nutr, 59(6): 768-75. [Abstract] [Full-text]
4. Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection.
   Pediatrics, 115(6): e706-9. [Abstract] [Full-text]
5. Blueprinting the regulatory response of Escherichia coli to the urinary tract.
   Trends Microbiol, 13(6): 246-8. [Abstract] [Full-text]
6. Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study.
   Chemotherapy, 51(2): 162-6. [Abstract] [Full-text]
7. In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
   Chemotherapy, 51(2): 64-9. [Abstract] [Full-text]
8. Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer.
   FEBS Lett, 579(15): 3317-22. [Abstract] [Full-text]
9. Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries.
   J Antimicrob Chemother, 55(6): 928-37. [Abstract] [Full-text]
10. Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli.
    J Antimicrob Chemother, 55(6): 938-43. [Abstract] [Full-text]
11. Prevention of nosocomial catheter-associated urinary tract infections through computerized feedback to physicians and a nurse-directed protocol.
    Am J Med Qual, 20(3): 121-6. [Abstract] [Full-text]
12. Emergence of antibiotic resistance amongst hospital-acquired urinary tract infections and pharmacokinetic/pharmacodynamic considerations.
    J Hosp Infect, 60(3): 191-200. [Abstract] [Full-text]
13. Defective expression of Tamm-Horsfall protein/uromodulin in COX-2-deficient mice increases their susceptibility to urinary tract infections.
    Am J Physiol Renal Physiol, 289(1): F49-60. [Abstract] [Full-text]
14. Occurrence of hlyA and sheA genes in extraintestinal Escherichia coli strains.
    J Clin Microbiol, 43(6): 2965-8. [Abstract] [Full-text]
15. Chemokine response to febrile urinary tract infection.
    Kidney Int, 68(1): 62-70. [Abstract] [Full-text]
16. Glycosaminoglycans in childhood urinary tract infections.
    Pediatr Nephrol, 20(7): 937-9. [Abstract] [Full-text]
17. Imaging strategies in pediatric urinary tract infection.
    Eur Radiol, 15(7): 1283-8. [Abstract] [Full-text]
18. The presence of vesicoureteric reflux does not identify a population at risk for renal scarring following a first urinary tract infection.
    Arch Dis Child, 90(7): 733-6. [Abstract] [Full-text]
19. Noninvasive biophotonic imaging for monitoring of catheter-associated urinary tract infections and therapy in mice.
    Infect Immun, 73(7): 3878-87. [Abstract] [Full-text]
20. Effect of confounding in the association between circumcision status and urinary tract infection.
    J Infect, 51(1): 59-68. [Abstract] [Full-text]
21. Mycoplasma hominis and Ureaplasma urealyticum in patients with sterile pyuria.
    J Infect, 51(1): 54-8. [Abstract] [Full-text]
22. Diagnostic value and cost utility analysis for urine Gram stain and urine microscopic examination as screening tests for urinary tract infection.
    Urol Res, 33(3): 220-2. [Abstract] [Full-text]
23. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years.
    Int J Antimicrob Agents, 26(1): 75-7. [Abstract] [Full-text]
24. Piperacillin-sulbactam versus piperacillin-tazobactam: a multicentre, randomised, single-blind, controlled clinical trial.
    Int J Antimicrob Agents, 26(1): 22-7. [Abstract] [Full-text]

© 2004-2008 Urinary Tract Infection Research Today. All Rights Reserved.